Methylnitronitrosoguanidine
CAS No. 70-25-7
Methylnitronitrosoguanidine ( MNNG;1-Methyl-3-nitro-1-nitrosoguanidine )
Catalog No. M20603 CAS No. 70-25-7
Methylnitronitrosoguanidine (MNNG) is an alkylating agent with toxic and mutagenic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 51 | In Stock |
|
50MG | 73 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethylnitronitrosoguanidine
-
NoteResearch use only not for human use.
-
Brief DescriptionMethylnitronitrosoguanidine (MNNG) is an alkylating agent with toxic and mutagenic effects.
-
DescriptionMethylnitronitrosoguanidine (MNNG) is an alkylating agent with toxic and mutagenic effects.
-
SynonymsMNNG;1-Methyl-3-nitro-1-nitrosoguanidine
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA alkylator
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number70-25-7
-
Formula Weight147.09
-
Molecular FormulaC2H5N5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (849.82 mM)
-
SMILESCN(N=O)C(=N)N[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Slapikoff S A Andon B M Thilly W G . Comparison of toxicity and mutagenicity of methylnitrosourea methylnitronitrosoguanidine and ICR-191 among human lymphoblast lines[J]. Mutation Research 1980 70(3):365-371.
molnova catalog
related products
-
Methylnitronitrosogu...
Methylnitronitrosoguanidine (MNNG) is an alkylating agent with toxic and mutagenic effects.
-
OBI-3424
OBI-3424 (AST-3424, TH-3424) is a first-in-class, novel prodrug that selectively targets cancers overexpressing the enzyme AKR1C3, OBI-3424 is a highly selective prodrug that is converted by AKR1C3 to a DNA alkylating agent.
-
Cyclophosphamide
A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities; used to treat cancers and autoimmune diseases.